alpha-L-Fucp-(1->4)-[alpha-D-Glcp-(1->3)]-D-Galp

Term ID

CHEBI:146573

Synonyms

(2S,3S,4R,5S,6S)-2-[(2R,3S,4R,5R)-5,6-dihydroxy-2-(hydroxymethyl)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
6-deoxy-alpha-L-galactopyranosyl-(1->4)-[alpha-D-glucopyranosyl-(1->3)]-D-galactopyranose
alpha-D-gluco-hexopyranosyl-(1->3)-[6-deoxy-alpha-L-galacto-hexopyranosyl-(1->4)]-D-galacto-hexopyranose
alpha-L-fucopyranosyl-(1->4)-[alpha-D-glucopyranosyl-(1->3)]-D-galactopyranose
Glc(a1-3)[Fuc(a1-4)]Gal

Definition

A trisaccharide that is α-D-glucopyranosyl-(1→3)-D-galactopyranose in which the hydroxy group at position 4 of the D-galactopyranose moiety has been glycosylated by an α-L-fucopyranosyl group.

References

glygen:G01778PX
glytoucan:G01778PX
kegg.glycan:G03373

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->4)-[alpha-D-Glcp-(1->3)]-D-Galp

Phenotype where environments contain alpha-L-Fucp-(1->4)-[alpha-D-Glcp-(1->3)]-D-Galp

Phenotype modified by environments containing alpha-L-Fucp-(1->4)-[alpha-D-Glcp-(1->3)]-D-Galp

Phenotype affecting alpha-L-Fucp-(1->4)-[alpha-D-Glcp-(1->3)]-D-Galp

Human Disease Model